NASDAQ: MRNA - Moderna

Yield per half year: -50.33%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Moderna

Extended chart Simple chart
Financial Markets by TradingView

About Moderna

Moderna — американская биотехнологическая компания, занимающаяся исследованием и разработкой лекарств на основе исключительно РНК-мессенджера. В основе компании идея с mRNA — мессенджер РНК. Искуственно создается возбудитель вируса и создается препарат, который тренирует иммунную систему. Надо только расшифровать геном вируса, загрузить в комп, и на выходе будет состав вакцины. И так практически с любым вирусом. Проблема с доставкой этого мРНК в клетки человека. У Модерны 21 разработка, 10 проходят клинические испытания и НОЛЬ одобренных препаратов.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2018-12-07
ISIN US60770K1079
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.modernatx.com
Цена ао 33.85
Change price per day: -0.6207% (27.39)
Change price per week: +10.14% (24.715)
Change price per month: -13.53% (31.48)
Change price per 3 month: -34.27% (41.41)
Change price per half year: -50.33% (54.8)
Change price per year: -74.79% (107.97)
Change price per 3 year: -80.02% (136.25)
Change price per 5 year: -78.47% (126.44)
Change price per year to date: -34.54% (41.58)
All parameters

Underestimation

Title Value Grade
P/S 4.67 3
P/BV 1.39 9
P/E 8.96 9
EV/EBITDA -4.1 0
Total: 6.25

Efficiency

Title Value Grade
ROA, % -21.87 0
ROE, % -28.77 0
Total: 1.67

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0.0386

Debt

Title Value Grade
Debt/EBITDA -0.2092 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 1078.87 10
Yield Ebitda, % 344.76 10
Yield EPS, % 373.13 10
Total: 8
More

Institutions Volume Share, %
Baillie Gifford and Company 45654527 11.92
Vanguard Group Inc 33907072 8.86
Blackrock Inc. 25301692 6.61
State Street Corporation 14623723 3.82
Flagship Pioneering Inc. 9666038 2.52
Theleme Partners LLP 7349456 1.92
Wellington Management Group, LLP 7225579 1.89
Geode Capital Management, LLC 6549461 1.71
FMR, LLC 6393351 1.67
Goldman Sachs Group Inc 4551626 1.19



Head Job title Payment Year of birth
Mr. Stephane Bancel CEO & Director 4.55M 1973 (52 years)
Ms. Lavina Talukdar CFA Senior VP & Head of Investor Relations N/A
Ms. Shannon Thyme Klinger Chief Legal Officer & Corporate Secretary 1.39M 1971 (54 years)
Dr. Stephen Hoge M.D. President 1.92M 1977 (48 years)
Mr. James M. Mock Chief Financial Officer 1.4M 1977 (48 years)
Dr. Jerh Collins Ph.D. Chief Technical Operations & Quality Officer N/A 1967 (58 years)
Mr. Brad Miller Chief Information Officer N/A 1974 (51 year)
Colleen Hussey Senior Director of Corporate Communications N/A
Ms. Tracey Franklin Chief Human Resources Officer N/A 1981 (44 years)
Dr. Melanie Ivarsson M.B.A., Ph.D. Chief Development Officer N/A

Address: United States, Cambridge, 200 Technology Square - open in Google maps, open in Yandex maps
Website: http://www.modernatx.com